Triumph GZBO

The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and chronic kidney disease (CKD).

This trial is currently in follow-up and is not accepting new patients. To be considered for similar trials, please complete the form below.